thk-5351

Small moleculeexperimentalImaging agent

Clinical trial activity

9 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
7
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2015 (NCT02686216)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetOTHER

    Diagnostic

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Loading structure…

SMILES

CNc1ccc(-c2ccc3cc(OC[C@H](O)CF)ccc3n2)cn1
Mol. weight
327.36 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Imaging
18-fluorine

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 18f thk-5351
  • 18f-thk-5351
  • thk-5351
  • thk-5351

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04318626Phase 2May 1, 2020Chang Gung University
NCT03430869Phase 2Mar 23, 2018Chang Gung University
NCT04572477Phase 2Jun 1, 2017Chang Gung University
NCT03024944Phase 2Jun 1, 2017Columbia University, National Institute on Aging (NIA)
NCT03112096Phase 1May 17, 2017University of Ulsan
NCT02884492Phase 2Jul 1, 2016Columbia University, National Institute on Aging (NIA)
NCT04588649Phase 2Jan 4, 2016Chang Gung University
NCT02656498Phase 2Jan 1, 2016Korea Health Industry Development Institute, Sungkyunkwan University, University of Ulsan
NCT02686216Phase 1Dec 1, 2015Chang Gung University
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chang Gung UniversityAcademic/Hospital5522015
Columbia UniversityAcademic/Hospital2212016
National Institute on Aging (NIA)Government2012016
University of UlsanAcademic/Hospital2222016
Korea Health Industry Development InstituteAcademic/Hospital1012016
Sungkyunkwan UniversityAcademic/Hospital1012016
6 organizations
Page 1 / 1